Publicaciones en colaboración con investigadores/as de Queen Mary University of London (38)

2024

  1. Assessing the role of Chemokine (C–C motif) ligand 14 in AKI: a European consensus meeting

    Renal Failure, Vol. 46, Núm. 1

  2. LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial

    The Lancet, Vol. 403, Núm. 10445, pp. 2695-2708

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. An external quality assessment feasibility study; cross laboratory comparison of haemagglutination inhibition assay and microneutralization assay performance for seasonal influenza serology testing: A FLUCOP study

    Frontiers in Immunology, Vol. 14

  3. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  4. Maresin 1 activates brown adipose tissue and promotes browning of white adipose tissue in mice

    Molecular Metabolism, Vol. 74

  5. Resolvin D2 Attenuates Cardiovascular Damage in Angiotensin II-Induced Hypertension

    Hypertension, Vol. 80, Núm. 1, pp. 84-96

2022

  1. A first update on mapping the human genetic architecture of COVID-19

    Nature

  2. Angiography-derived physiology guidance vs usual care in an All-comers PCI population treated with the healing-targeted supreme stent and Ticagrelor monotherapy: PIONEER IV trial design

    American Heart Journal, Vol. 246, pp. 32-43

  3. Association between use of enhanced recovery after surgery protocols and postoperative complications in colorectal surgery in Europe: The EuroPOWER international observational study

    Journal of Clinical Anesthesia, Vol. 80

  4. Pituitary MRI Features in Acromegaly Resulting From Ectopic GHRH Secretion From a Neuroendocrine Tumor: Analysis of 30 Cases

    The Journal of clinical endocrinology and metabolism, Vol. 107, Núm. 8, pp. e3313-e3320

  5. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  6. Stroke genetics informs drug discovery and risk prediction across ancestries

    Nature, Vol. 611, Núm. 7934, pp. 115-123

  7. Whole-genome sequencing reveals host factors underlying critical COVID-19

    Nature, Vol. 607, Núm. 7917, pp. 97-103

2021

  1. Current clinical practice in disabling and chronic migraine in the primary care setting: results from the European My-LIFE anamnesis survey

    BMC Neurology, Vol. 21, Núm. 1

  2. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

  3. Need of guidance in disabling and chronic migraine identification in the primary care setting, results from the european MyLife anamnesis survey

    BMC Family Practice, Vol. 22, Núm. 1

  4. Operator preference and determinants of size selection when additional intermediate-size aortic transcatheter heart valves are made available

    International Journal of Cardiology, Vol. 338, pp. 168-173

2019

  1. Autologous bone marrow expanded mesenchymal stem cells in patellar tendinopathy: Protocol for a phase I/II, single-centre, randomized with active control PRP, double-blinded clinical trial

    Journal of Orthopaedic Surgery and Research, Vol. 14, Núm. 1

  2. Glucose-dependent phosphorylation signaling pathways and crosstalk to mitochondrial respiration in insulin secreting cells

    Cell Communication and Signaling, Vol. 17, Núm. 1